Cellectis S.A.
CLLS
$1.53
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 12.72M | 16.20M | 8.06M | 4.53M | 283.00K |
| Total Other Revenue | 2.45M | 1.85M | 1.44M | 1.97M | 1.71M |
| Total Revenue | 15.17M | 18.05M | 9.50M | 6.50M | 1.99M |
| Cost of Revenue | -- | -- | -- | -- | 737.00K |
| Gross Profit | 15.17M | 18.05M | 9.50M | 6.50M | 1.25M |
| SG&A Expenses | 4.93M | 5.17M | 3.88M | 5.10M | 4.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 47.00K | -175.00K | -686.00K | -35.00K | 704.00K |
| Total Operating Expenses | 25.85M | 28.82M | 26.71M | 27.39M | 31.07M |
| Operating Income | -10.68M | -10.77M | -17.21M | -20.90M | -29.08M |
| Income Before Tax | 6.44M | -23.12M | -25.46M | 5.38M | -41.79M |
| Income Tax Expenses | 514.00K | -59.00K | -193.00K | -262.00K | 6.00K |
| Earnings from Continuing Operations | 5.92M | -23.06M | -25.27M | 5.64M | -41.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 0.00 |
| Net Income | 5.92M | -23.06M | -25.27M | 5.64M | -41.80M |
| EBIT | -10.68M | -10.77M | -17.21M | -20.90M | -29.08M |
| EBITDA | -7.45M | -8.00M | -14.47M | -18.33M | -26.41M |
| EPS Basic | 0.06 | -0.23 | -0.28 | 0.08 | -0.64 |
| Normalized Basic EPS | 0.03 | -0.12 | -0.18 | 0.05 | -0.31 |
| EPS Diluted | 0.06 | -0.23 | -0.28 | -0.15 | -0.64 |
| Normalized Diluted EPS | 0.03 | -0.12 | -0.18 | 0.03 | -0.31 |
| Average Basic Shares Outstanding | 100.09M | 100.09M | 89.85M | 71.81M | 65.23M |
| Average Diluted Shares Outstanding | 100.09M | 100.09M | 89.85M | 103.09M | 65.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |